Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
CPA Canada appoints eight directors as new governance model takes effect - 2Allow Innovative Progressions To have a Tremendous Effect
- 3What to watch for as NASA’s historic Artemis II crew prepares to lift off toward the moon
- 4Hamas propaganda expert explains Israel's internal conflicts influenced Hamas's Oct. 7 assault
- 5SpaceX launches Starlink missions in dual-coast spaceflight doubleheader (videos)
- Parents search for children missing since a volcanic eruption in Colombia 40 years ago
- 7 Delightful Ferris Wheels, Do You Like Them?
- Tatiana Schlossberg, a granddaughter of JFK, is dead at 35 after cancer diagnosis
- The Most Paramount Crossroads in Olympic History
- Israel says it will keep control over part of southern Lebanon after war with Hezbollah ends
- King Charles III says he is reducing cancer treatment schedule in 2026
- Israel intensifies Lebanon attacks and hits areas not in Hezbollah's control
- MacArthur Foundation awards $100M to outbreak surveillance network, a boost amid global health cuts
- Why most Jewish Israelis back the death penalty for terrorists
